EMR moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for EMR just turned positive on September 22, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 213 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 151 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 61 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 59%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EMR as a result. In 57 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Tickeron Price Growth Rating for this company is 21 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.363) is normal, around the industry mean (5.342). P/E Ratio (34.877) is within average values for comparable stocks, (66.065). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.014) settles around the average of (0.014) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
IQSU saw its Momentum Indicator move below the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 63 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 77%.
The Moving Average Convergence Divergence Histogram (MACD) for IQSU turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In 39 of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
IQSU moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQSU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
IQSU broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where IQSU advanced for three days, in 277 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 305 of 353 cases where IQSU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
EMR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 38 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 21 | |
SMR RATING 1..100 | 62 | |
PRICE GROWTH RATING 1..100 | 21 | |
P/E GROWTH RATING 1..100 | 33 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EMR | IQSU | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 59% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 67% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 59% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 83% |
| Advances ODDS (%) | 4 days ago 62% | 11 days ago 82% |
| Declines ODDS (%) | 9 days ago 57% | 3 days ago 71% |
| BollingerBands ODDS (%) | N/A | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 55% | 1 day ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EMR’s FA Score shows that 3 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EMR’s TA Score shows that 5 TA indicator(s) are bullish.
EMR (@Industrial Machinery) experienced а -0.22% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -9.26%. For the same industry, the average monthly price growth was -10.37%, and the average quarterly price growth was -19.46%.
EMR is expected to report earnings on Nov 10, 2026.
The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.
A.I.dvisor indicates that over the last year, IQSU has been loosely correlated with EMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IQSU jumps, then EMR could also see price increases.
| Ticker / NAME | Correlation To IQSU | 1D Price Change % | ||
|---|---|---|---|---|
| IQSU | 100% | -1.45% | ||
| EMR - IQSU | 54% Loosely correlated | -0.42% | ||
| MS - IQSU | 51% Loosely correlated | -0.84% | ||
| DAL - IQSU | 50% Loosely correlated | -3.47% | ||
| C - IQSU | 49% Loosely correlated | +0.85% | ||
| COF - IQSU | 47% Loosely correlated | +1.45% | ||
More | ||||